Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function
- 1 January 1992
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 19 (1) , 61-67
- https://doi.org/10.1016/s0272-6386(12)70204-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- PREDNISOLONE AND CHLORAMBUCIL TREATMENT IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH DETERIORATING RENAL FUNCTIONThe Lancet, 1988
- Idiopathic membranous nephropathy: The natural history of untreated patientsKidney International, 1988
- A controlled trial of cyclophosphamide in patients with membranous glomerulonephritisKidney International, 1987
- Prognosis and treatment of membranous nephropathyKidney International, 1986
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984
- Membranous Nephropathy: Response to Steroids and ImmunosuppressionAmerican Journal of Nephrology, 1981
- A Controlled Study of Short-Term Prednisone Treatment in Adults with Membranous NephropathyNew England Journal of Medicine, 1979
- Long-term prognosis of idiopathic membranous glomerulonephritisThe American Journal of Medicine, 1979